Corporate Profile

Rhythm is a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare genetic disorders of obesity. More >>

Recent NewsMore >>
Rhythm Pharmaceuticals to Present at 18th Annual Needham Healthcare Conference
Rhythm Pharmaceuticals Announces Promising Clinical Data in MC4R Pathway Heterozygous Obesity and Strategy for Further Development
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
RYTM (Common Stock) $25.96 Stock is Up 0.27 (0.00%)04/23/19 4:00 p.m. ET
Stock chart for: RYTM.O.  Currently trading at $25.96 with a 52 week high of $37.23 and a 52 week low of $22.10.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources
Upcoming EventsMore >>
There are currently no events scheduled.